Hunter Shkolnik Comments on Proposed Opioid Settlement
December 5, 2019
Source: Daily Stock Dish
Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.
The deal is “overvalued to make the settlement look better,” said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300 federal lawsuits consolidated in the U.S. District Court in Cleveland.
“I don’t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,” he told Reuters.
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.
Download
Featured Attorneys
Related Articles
Personal Injury on Airplanes
April 27, 2016
It is no surprise to anyone reading this blog or for anyone who has traveled at all that accidents happen on planes. A whole host of things can happen on a plane that would warrant a passenger to seek compensation from the airline carrier. There are factors that are beyond the control of the airlines,…Read the article
The Lethal Threat of Asbestos at Home and Work
January 13, 2016
Asbestos is a group of minerals with microfibers that are resistant to fire, chemicals, and heat. They do not conduct electricity, either, which made them a widely-used substance in the automotive and construction fields at the end of the 19th century and into the 20th. Asbestos was used in concrete structures, fire-retardant coatings, bricks, fireplace…Read the article